| abstract |
The invention relates to manufacturing processes of the new title compounds. which can be used in medicine as a remedy, which is also an object of the invention "The compounds having the structure wherein Y is -Li2 ~ CH-CH ™ or (CH2) m1, wherein m1 is 1, 3 or 4, have Reactivity in the ovarian prostaglandin test on mice, but strong vasodilatory PJigenschaften with delayed biological effects, but reduced side effects. formula |